Last reviewed · How we verify
NCT03530449
Evaluation of the Repeatability and Reproducibility of OCTA Image Quality With the Heidelberg Engineering SPECTRALIS With OCT Angiography Module
trial testing OCT Angiography in Retinal Vascular in 39 participants. Terminated before completion.
15 September 2018
Quick facts
| Lead sponsor | Heidelberg Engineering GmbH |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 39 |
| Start date | 30 April 2018 |
| Primary completion | 15 September 2018 |
| Estimated completion | 15 September 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- OCT Angiography
- Color Fundus Photography
- Optical Coherence Tomography
Conditions studied
- Retinal Vascular — all drugs for Retinal Vascular →
- Normal Eyes — all drugs for Normal Eyes →
Sponsor
Heidelberg Engineering GmbH
Who can join
22 and older, any sex, with Retinal Vascular or Normal Eyes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Repeatability and Reproducibility of OCTA Image Quality with the Heidelberg Engineering SPECTRALIS
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03530449
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of OCT Angiography
Trials testing the same drug.
- NCT05699668 — Preterm Infants REtinalMicrovascular Alterations by Means of OCT Angiography · NA · unknown
- NCT04604002 — Evaluation of Additional Heidelberg Engineering SPECTRALIS With OCT Angiography Module (OCTA Module) Scan Types · completed
- NCT03279939 — Evaluation of Heidelberg Engineering SPECTRALIS With OCT Angiography Module · completed
Other Heidelberg Engineering GmbH trials
Trials by the same sponsor.
- NCT07338461 — High Resolution Imaging OCT Study · NA · not yet recruiting
- NCT06397976 — The Heidelberg Engineering ANTERION Software Comparison Precision and Agreement Study · terminated
- NCT05051813 — The Heidelberg Engineering ANTERION Corneal Epithelium Thickness Precision and Agreement Study · completed
- NCT04961398 — Evaluation of Heidelberg Engineering SPECTRALIS OCT Signal to Noise Ratio Effect on Parameter Measurements · completed
- NCT04661124 — Evaluation of the Heidelberg Engineering SPECTRALIS With Flex Module for In-vivo Imaging in the Supine Position · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03530449 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Heidelberg Engineering GmbH
- Last refreshed: 28 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03530449.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing